TY  - JOUR
AU  - Vera, R
AU  - Dotor, E
AU  - Feliu, J
AU  - González, E
AU  - Laquente, B
AU  - Macarulla, T
AU  - Martínez, E
AU  - Maurel, J
AU  - Salgado, M
AU  - Manzano, J L
PY  - 2016
DO  - 10.1007/s12094-016-1586-x
SN  - 1699-048X
UR  - http://hdl.handle.net/10668/2590
T2  - Clinical & Translational Oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
AB  - Pancreatic cancer remains an aggressive disease with a 5 year survival rate of 5%. Only 15% of patients with pancreatic cancer are eligible for radical surgery. Evidence suggests a benefit on survival with adjuvant chemotherapy (gemcitabine o...
LA  - en
PB  - Springer Verlag
KW  - Pancreatic cancer
KW  - Treatment
KW  - Diagnostic
KW  - Guidelines
KW  - Neoplasias pancreáticas
KW  - Guías de práctica clínica como asunto
KW  - Factores de riesgo
KW  - España
KW  - Humanos
KW  - Medical Subject Headings::Diseases::Neoplasms::Neoplasms by Site::Digestive System Neoplasms::Pancreatic Neoplasms
KW  - Medical Subject Headings::Health Care::Health Services Administration::Quality of Health Care::Quality Assurance, Health Care::Guidelines as Topic::Practice Guidelines as Topic
KW  - Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Statistics as Topic::Probability::Risk::Risk Factors
KW  - Medical Subject Headings::Geographicals::Geographic Locations::Europe::Spain
KW  - Medical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans
TI  - SEOM Clinical Guideline for the treatment of pancreatic cancer (2016).
TY  - research article
ER  -